Report
Sanjeev Kumar Singh
EUR 120.00 For Business Accounts Only

MOSL : SHREE CEMENT: Cost pressures and weak realization hurt

Shree Cement: Cost pressures and weak realization hurt

(SRCM IN, Mkt Cap USD9.3b, CMP INR21163, TP INR21510, 2% Upside, Neutral)

Announces changes in the Board's composition

  • SRCM, as expected, reported a weak 2QFY23, led by higher variable costs and weak realization. EBITDA fell 42% YoY to INR5.2b (est. INR5.4b) and EBITDA/t came in at a 28-quarter low at INR701 (est. INR770), down 51% YoY and 36% QoQ). Profit fell 67% YoY to INR1.9b (est. INR2.1b).
  • Changes in the Board composition: 1) Mr. B. G. Bangur will be Chairman Emeritus (earlier: Chairman); 2) Mr. H. M. Bangur will be Chairman (earlier: MD); 3) Mr. Prashant Bangur will be Vice Chairman (earlier: Joint MD); and 4) Mr. Neeraj Akhoury (former MD & CEO of ACEM/ACC) has been designated as MD for a period of five years.
  • We have kept our earnings estimates largely intact. Valuations, at 17.7x FY24E EV/EBITDA, appears rich considering the narrowing of cost benefits v/s its peers. We maintain our Neutral rating on the stock, valuing it at 16x Sep'24E EV/EBITDA (from Mar'24 earlier).

Sales volume above our estimate, but realization disappoints

  • Revenue/EBITDA/profit stood at INR37.8b/INR5.2b/INR1.9b, +18%/-42%/-67% YoY and 1%/3%/9% below our estimates. Sales volumes rose 18% YoY as Cement volume grew 14.5%. Realization was flat YoY, but declined by 9% QoQ (7% lower than our estimate). Lower power sales and higher clinker volumes (impact of ~1% on realization) aided pressure on realization.
  • OPEX/t increased by 20% YoY, led by: 1) a 66% increase in variable costs on higher coal and petcoke prices, and 2) a 3% rise in freight cost. Employee cost/t fell 12% on higher volumes and other expense declined by 10% YoY. Higher costs led to 14pp YoY and 6pp QoQ decline in OPM to 13.8%.
  • Depreciation/interest cost rose 45%/22% YoY. Higher interest cost was largely due to an increase in short-term borrowings (up INR6.9b in 1HFY23).
  • Revenue grew 20% YoY in 1HFY23, backed by a 6%/14% YoY rise in blended realization/volume. OPEX/t increased by 23% YoY, which led to 30% drop in EBITDA to INR13.4b and ~12pp YoY decline in OPM to 16.8%. Profit declined by 59% YoY to INR5.1b.
  • OCF in 1HFY23 declined by 26% YoY to INR7.3b due to lower profitability, which was partly offset by an improvement in working capital and lower tax outgo. FCF turned negative (INR4.6b) v/s INR2.3b in 1HFY22, due to higher capex of INR12b v/s INR7.6b in 1HFY22.
Underlying
Shree Cement Limited

Shree Cements is engaged in the manufacture of cement. Co.'s brands include Shree Ultra, Bangur Cement, and Rockstrong Cement. Shree Ultra is Co.'s flagship brand. This brand has two variants, Shree Ultra OPC and Shree Ultra Jung Rodhak Cement. Shree Ultra Jung Rodhak Cement has unique rust prevention properties. Bangur Cement, launched as a premium brand in the market, is designed to meet the high end market segment. Rockstrong Cement is the youngest brand. This brand has high performance and ability to withstand exceptionally harsh environment conditions.

Provider
Motilal Oswal
Motilal Oswal

​Motilal Oswal Financial Services Ltd. is a reputed name in Financial Services and Online Trading with group companies providing services such as Private Wealth Management, Retail Broking and Distribution, Institutional Broking, Asset Management, Investment Banking, Private Equity, Commodity Broking, Currency Broking, Principal Strategies & Home Finance. 

Motilal Oswal Securities is a group company of Motilal Oswal Financial Service Limited which started as a stock trading company and has blossomed into well diversified firm offering a range of financial products and services. Motilal Oswal has built a reputation as the source for best stock trading company and this has taken a wealth of experience, knowledge and expertise, constantly working in tandem, over the years.

Analysts
Sanjeev Kumar Singh

Other Reports on these Companies
Other Reports from Motilal Oswal

ResearchPool Subscriptions

Get the most out of your insights

Get in touch